Bio-Rad Laboratories Pioneer Antibody Discovery Platform

Bio-Rad Laboratories has launched its Pioneer Antibody Discovery Platform, an antibody discovery service specifically designed to develop best-in-class biologic candidates.

The platform features a state-of-the-art phage display library engineered to include more than 200 billion unique sequences and capable of identifying high-affinity antibody candidates using the company’s SpyDisplay selection technology. The antibody library is optimised for candidates that are suitable for drug development.

Tailored to each client’s specific requirements, the platform uses TrailBlazer technology to provide prototypes of therapeutic antibodies in a multitude of formats for streamlined lead identification. Final IgG antibodies will be delivered functionally characterised with a complete data package and sequences. Users will have exclusivity and ownership of antibody sequences.